Deutsche Bank AG Has $78.61 Million Stake in STERIS plc (NYSE:STE)

Deutsche Bank AG increased its stake in STERIS plc (NYSE:STE - Free Report) by 19.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 382,407 shares of the medical equipment provider's stock after purchasing an additional 62,968 shares during the quarter. Deutsche Bank AG owned approximately 0.39% of STERIS worth $78,608,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. EP Wealth Advisors LLC raised its position in shares of STERIS by 20.1% in the fourth quarter. EP Wealth Advisors LLC now owns 1,011 shares of the medical equipment provider's stock valued at $208,000 after purchasing an additional 169 shares during the period. Colonial Trust Co SC grew its stake in STERIS by 5.5% in the 4th quarter. Colonial Trust Co SC now owns 11,955 shares of the medical equipment provider's stock valued at $2,457,000 after buying an additional 622 shares during the last quarter. Centiva Capital LP bought a new position in STERIS in the 4th quarter worth $636,000. Captrust Financial Advisors raised its holdings in STERIS by 65.7% in the 4th quarter. Captrust Financial Advisors now owns 16,743 shares of the medical equipment provider's stock worth $3,442,000 after acquiring an additional 6,638 shares during the period. Finally, Cary Street Partners Financial LLC acquired a new position in STERIS during the 4th quarter worth $80,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Up 0.3%

STE stock opened at $226.54 on Monday. STERIS plc has a twelve month low of $200.98 and a twelve month high of $248.24. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The company has a market cap of $22.26 billion, a PE ratio of 48.10 and a beta of 0.96. The business's 50-day simple moving average is $223.40 and its 200 day simple moving average is $218.80.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th will be issued a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. The ex-dividend date is Tuesday, June 10th. STERIS's payout ratio is presently 48.41%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on STE. Piper Sandler raised their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Stephens raised STERIS to a "strong-buy" rating in a report on Thursday, May 1st. JMP Securities reaffirmed a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research report on Thursday, April 10th. Finally, Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research report on Monday, April 7th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.